Article Details

MacroGenics Announces Closure of CP-MGA271-06 Study Evaluating Enoblituzumab plus ...

Retrieved on: 2022-07-09 18:13:56

Tags for this article:

Click the tags to see associated articles and topics

MacroGenics Announces Closure of CP-MGA271-06 Study Evaluating Enoblituzumab plus .... View article details on HISWAI: https://pipelinereview.com/index.php/2022070981217/Antibodies/MacroGenics-Announces-Closure-of-CP-MGA271-06-Study-Evaluating-Enoblituzumab-plus-Checkpoint-Inhibition-in-Head-and-Neck-Cancer.html

Excerpt

The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up